Clinical Trials
Discover the future of medicine today. Yale Medicine currently offers 693 active clinical trials across our hospitals and care centers, providing our patients with early access to many of the world’s most advanced therapies. Yale Center for Clinical Investigation (YCCI) supports, coordinates, and oversees clinical trials, ensuring the safety of trial volunteers.
For more information about cancer-related trials, call us at 203-785-5702. For all other trials, call 877-978-8343.
12 Results
- Thyroid and Other Endocrine Cancers
A Phase 1 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Neoplasms
- Thyroid and Other Endocrine Cancers
- Phase 1 Cancers
A Phase 1, Open-label, Multicenter, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of KQB168 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Malignancies
- Colorectal Cancer
- Stomach and Esophagus
- Kidney Cancer
- Head and Neck Cancers
- Lung Cancer
- Thyroid and Other Endocrine Cancers
- Phase 1 Cancers
- Gynecological Cancers
A Phase 1/2 Dose Escalation Study of CRN09682 With an Expansion Phase in Participants With Progressive Metastatic Somatostatin Receptor Type 2 (SST2)-Expressing Neuroendocrine Neoplasms (NENs) and Other SST2-Expressing Solid Tumors
- Thyroid and Other Endocrine Cancers
A Phase 1/2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors
- Colorectal Cancer
- Stomach and Esophagus
- Head and Neck Cancers
- Lung Cancer
- Thyroid and Other Endocrine Cancers
- Phase 1 Cancers
- Breast Cancer
A Phase 3, Randomized, Multicenter, Open-Label Study of IDRX-42 (GSK6042981) Versus Sunitinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) After Imatinib Therapy (StrateGIST 3)
- Stomach and Esophagus
- Thyroid and Other Endocrine Cancers
A Phase III Study of Targeted Therapy vs. Chemotherapy in Patients with Thyroid Cancer
- Thyroid and Other Endocrine Cancers
- Gender:All Genders
- Age:18 years and older
A Randomized, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Paltusotine in Adults With Carcinoid Syndrome Due to Well-Differentiated Neuroendocrine Tumors
- Thyroid and Other Endocrine Cancers
Endometrium and Metabolism
- Thyroid and Other Endocrine Cancers
- Gynecological Cancers
First-In-Human, Open-Label, Dose Escalation and Expansion Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of GEN1106 in Participants With Solid Tumors
- Stomach and Esophagus
- Head and Neck Cancers
- Lung Cancer
- Bladder Cancer
- Thyroid and Other Endocrine Cancers
- Phase 1 Cancers
- Breast Cancer
PROgram to address psychosocial Support, clinical outcomes, and genomic insights for Patients with EaRly onset cancers
- Colorectal Cancer
- Sarcoma Cancers
- Stomach and Esophagus
- Kidney Cancer
- Head and Neck Cancers
- Liver Cancer
- Lung Cancer
- Gynecological Cancers
- Pancreatic Cancer
- Prostate Cancer
- Thyroid and Other Endocrine Cancers
- Breast Cancer
1-10 of 12 Results